V. Eberlein

发表

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

M. B. Cardoso, J. Münch, A. Zelikin, 2022, Advanced science.

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation

C. Berking, L. Heinzerling, G. Schuler, 2021, International journal of molecular sciences.

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

K. Überla, A. Ensser, C. Thirion, 2021, Nature Communications.

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

R. Klopfleisch, J. Speakman, D. Görlich, 2022, iScience.

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization

K. Überla, A. Ensser, C. Thirion, 2021, bioRxiv.

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model

K. Überla, H. Jäck, S. Ciesek, 2021, bioRxiv.

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses

J. Münch, J. Shorter, M. Frick, 2022, JACS Au.

Detection of antimicrobial residues in camel milk : suitability of various commercial microbial inhibitor tests as screening tests

U. Wernery, E. Märtlbauer, A. Strasser, 2006 .

Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

S. Ulbert, C. Hesse, Julia Finkensieper, 2023, Viruses.